The efficacy and safety of the hematoma block for fracture reduction in closed, isolated fractures.
J P Furia, R J Alioto, J D Marquardt
https://pubmed.ncbi.nlm.nih.gov/9172249Actively Recruiting
Led by Beth Israel Deaconess Medical Center · Updated on 2026-03-03
115
Participants Needed
1
Research Sites
17 weeks
Total Duration
B
Beth Israel Deaconess Medical Center
Lead Sponsor
H
Harvard University
Collaborating Sponsor
This research aims to evaluate the effectiveness of ultrasound-guided hematoma blocks compared to traditional "blind" hematoma blocks for pain relief during the reduction of distal radius fractures. Hematoma blocks involve injecting lidocaine directly into the fracture site to provide analgesia. While effective, traditional blocks can be challenging when swelling or body shape obscures the fracture line. Ultrasound guidance has shown promise in improving pain relief in similar procedures but has not been compared in a randomized trial for this use. Participants will be randomly assigned to one of two groups. One group will receive a bedside ultrasound-guided hematoma block with 0.25% bupivacaine for analgesia. The other group will receive the traditional hematoma block without ultrasound guidance, also using 0.25% bupivacaine. The study will compare the pain relief achieved by these two methods during fracture reduction. During the study, participants’ pain levels will be assessed using a Visual Analog Scale four hours after the procedure begins. The study involves adult patients with distal radius fractures presenting in the emergency department. Researchers will monitor pain reduction effectiveness and safety during the study period. Participation includes the treatment procedure and follow-up pain assessments to evaluate outcomes.
CONDITIONS
Hematoma Block for Distal Radius Fracture
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single treatment session
Participants receive a hematoma block for analgesia to reduce pain during distal radius fracture reduction. They are randomized to receive either an ultrasound-guided hematoma block or a traditional hematoma block without ultrasound guidance.
1 treatment visit (in-person)
Duration - 4 hours after treatment
Participants are observed to assess pain reduction and any immediate effects after the hematoma block procedure.
1 follow-up visit (in-person)
Total: 1 location
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Actively Recruiting
B
Beatrice Hoffmann, MD
N
Nathan I Shapiro, MD MPH
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
J P Furia, R J Alioto, J D Marquardt
https://pubmed.ncbi.nlm.nih.gov/9172249R J Alioto, J P Furia, J D Marquardt
https://pubmed.ncbi.nlm.nih.gov/7776029G K Singh, R K Manglik, P K Lakhtakia...
https://pubmed.ncbi.nlm.nih.gov/1343612P Q Johnson, M A Noffsinger
https://pubmed.ncbi.nlm.nih.gov/1749663Kevin J Walker, Ken McGrattan, Kristine Aas-Eng...
https://pubmed.ncbi.nlm.nih.gov/19821368P Atkinson, R Lennon
https://pubmed.ncbi.nlm.nih.gov/12835377Chad S Crystal, Michael A Miller, Scott E Young
https://pubmed.ncbi.nlm.nih.gov/17297348Paul D Kiely, Dermot O'Farrell, John Riordan...
https://pubmed.ncbi.nlm.nih.gov/20006267